v3.26.3
Shareholders’ Equity and Equity Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Compensation recognized $ 18,498 $ 13,655 $ 56,589 $ 56,639
Cost of Sales | Cost of services - Molecular profiling services        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Compensation recognized 669 1,104 3,712 2,452
Cost of Sales | Cost of services - Pharma research and development services        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Compensation recognized 4 17 26 20
Selling and marketing expense        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Compensation recognized 4,501 3,322 13,310 6,554
General and administrative expense        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Compensation recognized 9,710 6,410 28,054 39,438
Research and development expense        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Compensation recognized $ 3,614 $ 2,802 $ 11,487 $ 8,175